NHC vs SGRY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NHC · National Healthcare$190.77 ▲ 1.18%
SGRY · Surgery Partners$26.78 ▲ 0.34%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NHC +46.5%
- SGRY +64.4%
Head to head
| Metric | NHC | SGRY |
|---|---|---|
| Price | $190.77 | $26.78 |
| Change today | ▲ 1.18% | ▲ 0.34% |
| Market cap | $2.99B | $3.50B |
| Return, 3 months | -16.2% | +92.0% |
| Return, year to date | +40.6% | +73.3% |
| Return, 1 year | +48.4% | +69.1% |
| P/E (TTM) | 26.4 | – |
| P/B | 2.7 | 2.1 |
| P/E percentile vs own 5y | 73rd | 54th |
| Dividend yield | 1.37% | – |
| Revenue growth (YoY, latest qtr) | +6.6% | -0.8% |
| Net profit growth (YoY) | -65.4% | -44.3% |
| Gross margin | 39.3% | 22.2% |
| Operating margin | 9.8% | 12.9% |
| Net margin | 7.2% | -2.6% |
| Return on equity | 10.5% | -5.1% |
| Analyst target vs. price | – | -22.9% |
| Analyst buy share | – | 14% |
| RSI (14) | 30 | 84 |
| 30-day volatility | 43.6% | 118.1% |
| Max drawdown, 1 year | -24.0% | -34.0% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SGRY is the largest of the group by market value.
- SGRY has returned the most over the past year.
- NHC is growing revenue fastest.
- NHC keeps the most profit per dollar of sales.
- NHC has been the calmest stock over the last 30 days.